Remetinostat (SHP-141) (Synonyms: SHP-141) |
رقم الكتالوجGC33290 |
Remetinostat (SHP-141) (SHP-141) هو مثبط قائم على حمض الهيدروكساميك لأنزيمات هيستون ديستيلاز (HDAC) وهو قيد التطوير لعلاج ورم الغدد الليمفاوية للخلايا التائية الجلدية.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 946150-57-8
Sample solution is provided at 25 µL, 10mM.
Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma[1].
[1]. Yijun Deng, et al. Process Development of the Soft Histone Deacetylate Enzyme Inhibitor SHP-141: Acylation of Methyl Paraben and Suberyl Hydroxamic Acid Formation. Org. Process Res. Dev. 2016, 20, 10, 1812-1820.
Average Rating: 5
(Based on Reviews and 39 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *